• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana.在博茨瓦纳抗逆转录病毒疗法(ART)覆盖率较高的情况下,与治疗相关的联系及开始接受ART的障碍和促进因素。
AIDS Care. 2020 Jun;32(6):722-728. doi: 10.1080/09540121.2019.1640843. Epub 2019 Jul 12.
2
Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.尼泊尔检测即治疗时代抗逆转录病毒疗法起始和维持的多层次决定因素:一项定性研究。
BMC Health Serv Res. 2024 Aug 13;24(1):927. doi: 10.1186/s12913-024-11311-6.
3
Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.测试而非治疗:南非夸祖鲁-纳塔尔省农村地区社区成员在获得普遍抗逆转录病毒治疗方面面临的障碍和促进因素的经验。
PLoS One. 2020 Sep 24;15(9):e0239513. doi: 10.1371/journal.pone.0239513. eCollection 2020.
4
Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study.博茨瓦纳围产期 HIV 感染青少年用药依从性的障碍:感知污名和对意外披露的恐惧:一项定性研究。
Biomed Res Int. 2019 Dec 2;2019:9623159. doi: 10.1155/2019/9623159. eCollection 2019.
5
Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.在博茨瓦纳实施普遍艾滋病毒检测和治疗以降低艾滋病毒发病率:Ya Tsie 研究。
Curr HIV/AIDS Rep. 2020 Oct;17(5):478-486. doi: 10.1007/s11904-020-00523-0.
6
"She tells me the HIV is eating my brains": barriers and facilitators to antiretroviral therapy adherence among Eswatini adolescents living with HIV.“她告诉我艾滋病毒正在侵蚀我的大脑”:斯威士兰感染艾滋病毒青少年坚持抗逆转录病毒治疗的障碍与促进因素
AIDS Care. 2025 Feb;37(2):310-323. doi: 10.1080/09540121.2024.2443677. Epub 2024 Dec 30.
7
Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study.赞比亚患者坚持抗逆转录病毒治疗的障碍与促进因素:一项定性研究
SAHARA J. 2008 Sep;5(3):136-43. doi: 10.1080/17290376.2008.9724912.
8
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.乌干达艾滋病毒感染者儿童和青少年启动和完成结核病预防治疗的促进因素和障碍:青少年、照顾者和卫生工作者的定性研究。
AIDS Res Ther. 2024 Aug 29;21(1):59. doi: 10.1186/s12981-024-00643-2.
9
Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study.赞比亚卢萨卡市阻碍 HIV 患者启动抗逆转录病毒治疗的因素:一项定性研究。
AIDS Patient Care STDS. 2013 Apr;27(4):231-41. doi: 10.1089/apc.2012.0341. Epub 2013 Mar 26.
10
"Even if you're HIV-positive there's life after if you take your medication": experiences of people on long-term ART in South Africa: a short report.“即使你是艾滋病毒阳性患者,如果你按时服药,生活仍会继续”:南非长期接受抗逆转录病毒治疗者的经历:一份简短报告
AIDS Care. 2019 Aug;31(8):973-978. doi: 10.1080/09540121.2019.1597960. Epub 2019 Mar 27.

引用本文的文献

1
Lived experiences of adults living With HIV/AIDS receiving antiretroviral therapy at werabe comprehensive specialized hospital in Silte zone, Ethiopia.在埃塞俄比亚锡尔特地区韦拉贝综合专科医院接受抗逆转录病毒治疗的感染艾滋病毒/艾滋病成年人的生活经历。
Front Reprod Health. 2025 Jul 28;7:1494390. doi: 10.3389/frph.2025.1494390. eCollection 2025.
2
Universal "Test and Treat" for HIV Had Little Effect on Outcomes, but Missed Clinic Visits Threaten Success of Botswana's National Antiretroviral Treatment Program.针对艾滋病病毒的普遍“检测与治疗”对治疗结果影响甚微,但错过门诊就诊威胁着博茨瓦纳国家抗逆转录病毒治疗项目的成功。
AIDS Patient Care STDS. 2025 Jun;39(6):215-223. doi: 10.1089/apc.2025.0042. Epub 2025 May 20.
3
Perspectives of people living with HIV on barriers to timely ART initiation following referral for antiretroviral therapy: A qualitative study at an urban HIV clinic in Kampala, Uganda.乌干达坎帕拉一家城市艾滋病诊所的定性研究:艾滋病毒感染者对转诊接受抗逆转录病毒治疗后及时开始抗逆转录病毒治疗的障碍的看法。
PLOS Glob Public Health. 2023 Jul 26;3(7):e0001483. doi: 10.1371/journal.pgph.0001483. eCollection 2023.
4
Perceptions toward antiretroviral therapy and delayed ART initiation among people living with HIV in Changsha, China: mediating effects of treatment willingness.中国长沙 HIV 感染者对抗逆转录病毒治疗的认知及延迟 ART 起始治疗的原因:治疗意愿的中介作用
Front Public Health. 2023 Jun 13;11:1105208. doi: 10.3389/fpubh.2023.1105208. eCollection 2023.
5
Near-universal same-day linkage to ART care among newly diagnosed adults living with HIV: A cross-sectional study from primary health facilities, in urban Malawi.马拉维城市地区初级卫生设施的一项横断面研究:新诊断的成年HIV感染者几乎能在同一天获得抗逆转录病毒治疗护理
PLOS Glob Public Health. 2023 Jun 16;3(6):e0001436. doi: 10.1371/journal.pgph.0001436. eCollection 2023.
6
Identity management in the face of HIV and intersecting stigmas: A metasynthesis of qualitative reports from sub-Saharan Africa.面对艾滋病毒和交叉污名时的身份管理:撒哈拉以南非洲地区定性报告的元综合分析
PLOS Glob Public Health. 2023 Feb 1;3(2):e0000706. doi: 10.1371/journal.pgph.0000706. eCollection 2023.
7
"It's Better If I Die Because Even in the Hospital, There is a Stigma, People Still Gossip": Gossip as a Culturally Shaped Labeling Process and Its Implications for HIV-Related Stigma in Botswana.“如果我死了会更好,因为即使在医院,也会有耻辱感,人们仍然会八卦”:流言蜚语作为一种文化塑造的标签过程及其对博茨瓦纳艾滋病毒相关耻辱感的影响。
AIDS Behav. 2023 Aug;27(8):2535-2547. doi: 10.1007/s10461-023-03980-x. Epub 2023 Jan 17.
8
Causal Structural Learning on MPHIA Individual Dataset.MPHIA个体数据集上的因果结构学习
J Am Stat Assoc. 2022;117(540):1642-1655. doi: 10.1080/01621459.2022.2077209. Epub 2022 Jul 7.
9
Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.卫生保健机构中的污名化现象及其对青少年女孩和年轻妇女获得和使用 PrEP 的影响:来自南非的矛盾观点。
BMC Public Health. 2022 Oct 14;22(1):1916. doi: 10.1186/s12889-022-14236-z.
10
Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda-An evaluation of the HIV test and treat strategy.在乌干达,接受抗逆转录病毒疗法的住院 HIV 感染患者的起始治疗和结局——对 HIV 检测即治疗策略的评估。
PLoS One. 2022 Aug 19;17(8):e0268122. doi: 10.1371/journal.pone.0268122. eCollection 2022.

本文引用的文献

1
Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.博茨瓦纳年轻 HIV 阳性成年人中病毒学抑制不足。
J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715.
2
Rethinking retention: Mapping interactions between multiple factors that influence long-term engagement in HIV care.重新思考保留率:绘制影响 HIV 护理长期参与的多种因素之间相互作用的关系图。
PLoS One. 2018 Mar 14;13(3):e0193641. doi: 10.1371/journal.pone.0193641. eCollection 2018.
3
Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa.撒哈拉以南非洲地区五项普遍艾滋病毒检测和治疗试验的比较评估。
J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25048.
4
Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.在撒哈拉以南非洲地区,基于社区的策略以加强男性参与艾滋病病毒治疗流程。
PLoS Med. 2017 Apr 11;14(4):e1002262. doi: 10.1371/journal.pmed.1002262. eCollection 2017 Apr.
5
Good Health and Moral Responsibility: Key Concepts Underlying the Interpretation of Treatment as Prevention in South Africa and Zambia Before Rolling Out Universal HIV Testing and Treatment.良好健康与道德责任:在南非和赞比亚推行普遍艾滋病毒检测与治疗之前,“治疗即预防”理念背后的关键概念
AIDS Patient Care STDS. 2016 Sep;30(9):425-34. doi: 10.1089/apc.2016.0114.
6
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.博茨瓦纳在实现 2020 年艾滋病署 90-90-90 抗逆转录病毒治疗和病毒学抑制目标方面的进展:一项基于人群的调查。
Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24.
7
Facilitators and barriers in HIV linkage to care interventions: a qualitative evidence review.艾滋病病毒感染者获得治疗干预措施的促进因素和障碍:一项定性证据综述。
AIDS. 2016 Jun 19;30(10):1639-53. doi: 10.1097/QAD.0000000000001101.
8
Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia.纳米比亚温得和克地区艾滋病毒呈阳性的结核病患者在获取抗逆转录病毒治疗方面存在的障碍。
Int J Mycobacteriol. 2014 Dec;3(4):268-75. doi: 10.1016/j.ijmyco.2014.07.009. Epub 2014 Sep 4.
9
Empowering patients to link to care and treatment: qualitative findings about the role of a home-based HIV counselling, testing and linkage intervention in South Africa.增强患者获得护理和治疗的能力:关于南非一项基于家庭的艾滋病毒咨询、检测及转介干预措施作用的定性研究结果
AIDS Care. 2015;27(9):1162-7. doi: 10.1080/09540121.2015.1035633. Epub 2015 Apr 29.
10
Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study.社会支持作为预测 HIV 早期诊断、关联、保留和坚持 HIV 护理的指标:来自 STEPS 研究的结果。
J Assoc Nurses AIDS Care. 2014 Sep-Oct;25(5):405-13. doi: 10.1016/j.jana.2013.12.002. Epub 2014 Feb 6.

在博茨瓦纳抗逆转录病毒疗法(ART)覆盖率较高的情况下,与治疗相关的联系及开始接受ART的障碍和促进因素。

Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana.

作者信息

Kebaabetswe Poloko, Manyake Kutlo, Kadima Etienne, Auletta-Young Chloe, Chakalisa Unoda, Sekoto Tumalano, Dintwa Oarabile Makgabana, Mmalane Mompati, Makhema Joseph, Lebelonyane Refeletswe, Bachanas Pamela, Plank Rebeca, Gaolathe Tendani, Lockman Shahin, Holme Molly Pretorius

机构信息

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Harvard. T.H. Chan School of Public Health, Boston, MA, USA.

出版信息

AIDS Care. 2020 Jun;32(6):722-728. doi: 10.1080/09540121.2019.1640843. Epub 2019 Jul 12.

DOI:10.1080/09540121.2019.1640843
PMID:31298037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6954979/
Abstract

We conducted a qualitative study using focus groups and in-depth interviews to explore barriers to and facilitators of linkage-to-care and antiretroviral treatment (ART) initiation in Botswana. Participants were selected from communities receiving interventions through the Ya Tsie Study. Fifteen healthcare providers and 49 HIV-positive individuals participated. HIV-positive participants identified barriers including stigma, discrimination and overcrowded clinics, and negative staff attitudes; personal factors, such as a lack of acceptance of one's HIV status, non-disclosure, and gender differences; along with lack of social/family support, and certain religious beliefs. Healthcare providers cited delayed test results, poverty, and transport difficulties as additional barriers. Major facilitators were support from healthcare providers, including home visits, social support, and knowing the benefits of ART. Participants were highly supportive of universal ART as a personal health measure. Our results highlighted a persistent structural health facility barrier: HIV-positive patients expressed strong discontent with HIV care/treatment being delivered differently than routine healthcare, feeling inconvenienced and stigmatized by separately designated locations and days of service. This barrier was particularly problematic for highly mobile persons. Addressing this structural barrier, which persists even in the context of high ART uptake, could bring gains in willingness to initiate ART and improved adherence in Botswana and elsewhere.

摘要

我们开展了一项定性研究,采用焦点小组和深入访谈的方式,以探究博茨瓦纳在接受治疗和启动抗逆转录病毒治疗(ART)方面的障碍及促进因素。参与者选自通过亚齐研究接受干预措施的社区。15名医疗服务提供者和49名艾滋病毒呈阳性的个体参与了研究。艾滋病毒呈阳性的参与者指出的障碍包括耻辱感、歧视、诊所拥挤、工作人员态度消极;个人因素,如不接受自己的艾滋病毒感染状况、不透露病情以及性别差异;缺乏社会/家庭支持以及某些宗教信仰。医疗服务提供者提到检测结果延迟、贫困和交通困难是额外的障碍。主要的促进因素是医疗服务提供者的支持,包括家访、社会支持以及了解抗逆转录病毒治疗的益处。参与者高度支持将普及抗逆转录病毒治疗作为一项个人健康措施。我们的研究结果突出了一个持续存在的结构性卫生设施障碍:艾滋病毒呈阳性的患者对艾滋病毒护理/治疗与常规医疗保健的提供方式不同表示强烈不满,他们因单独指定的服务地点和日期而感到不便并受到耻辱感影响。这一障碍对流动性强的人来说尤其成问题。解决这一即使在抗逆转录病毒治疗使用率很高的情况下仍持续存在的结构性障碍,可能会提高博茨瓦纳及其他地区启动抗逆转录病毒治疗的意愿并改善依从性。